Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.95
+0.11000.13%
Post-market: 84.970.0200+0.02%19:49 EDT
Volume:8.21M
Turnover:697.41M
Market Cap:9.01B
PE:-16.89
High:85.01
Open:84.96
Low:84.92
Close:84.84
52wk High:85.01
52wk Low:31.00
Shares:106.10M
Float Shares:95.53M
Volume Ratio:8.52
T/O Rate:8.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0290
EPS(LYR):-4.9500
ROE:-42.45%
ROA:-26.28%
PB:7.56
PE(LYR):-17.16

Loading ...

Aug 28, 2026

Major Issues Report

Form 8-K - Current report
Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2026

Major Issues Report

Form 8-K - Current report
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities